CZSClass I
Retinol-Binding Protein, Antigen, Antiserum, Control
21 CFR 866.5765 / Immunology
CZS is the FDA product code for Retinol-Binding Protein, Antigen, Antiserum, Control, a class I device type, regulated under 21 CFR 866.5765. As of , FDA records hold 3 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- CZS
- Device name
- Retinol-Binding Protein, Antigen, Antiserum, Control
- Regulation
- 21 CFR 866.5765
- Device class
- Class I
- Review panel
- Immunology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 3
- Ingested recalls
- 0
Clearances, product code CZS
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1985 | 1 |
| 1996 | 1 |
| 1997 | 1 |
Applicants with the most clearances
Product code CZS| Applicant | Clearances |
|---|---|
| The Binding Site | 2 |
| Behring Diagnostics, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this code- Agilent Technologies Denmark ApS
- Agilent Technologies Singapore (International) Pte Ltd.
- Agilent Technologies, Inc.
- ATSI Logistics Center ApS
- Biobase Biodustry(shandong)co., Ltd
- Diazyme Laboratories, Inc.
- Dirui Industrial Co., Ltd.
- DRG Instruments GmbH
- DRG International, Inc.
- Immundiagnostik AG
- Shijiazhuang Hipro Biotechnology Co.,Ltd
- Siemens Healthcare Diagnostics Products Limited
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
